OTCPK:AVXA.F

Stock Analysis Report

Executive Summary

Novita Healthcare Limited engages in the development and commercialization of healthcare technologies in Australia.

Snowflake

Fundamentals

Adequate balance sheet and overvalued.

Risks

  • Novita Healthcare is not covered by any analysts.

Similar Companies

Share Price & News

How has Novita Healthcare's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

AVXA.F

2.5%

US Healthcare Services

-0.6%

US Market


1 Year Return

n/a

AVXA.F

10.2%

US Healthcare Services

0.7%

US Market

No trading data on AVXA.F.

No trading data on AVXA.F.


Share holder returns

AVXA.FIndustryMarket
7 Day0%2.5%-0.6%
30 Day0%-1.9%2.9%
90 Day0%-2.9%1.3%
1 Yearn/a10.3%10.2%2.9%0.7%
3 Yearn/a51.7%51.4%44.6%35.2%
5 Yearn/a52.0%51.1%61.9%44.2%

Price Volatility Vs. Market

How volatile is Novita Healthcare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Novita Healthcare undervalued based on future cash flows and its price relative to the stock market?

1.61x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Novita Healthcare to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Novita Healthcare to establish if it is available at substantial discount.


Price Based on Earnings

Novita Healthcare is loss making, we can't compare its value to the US Healthcare Services industry average.

Novita Healthcare is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Novita Healthcare, we can't assess if its growth is good value.


Price Based on Value of Assets

Novita Healthcare is good value based on assets compared to the US Healthcare Services industry average.


Next Steps

Future Growth

How is Novita Healthcare expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

27.7%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Novita Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Novita Healthcare performed over the past 5 years?

4.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Novita Healthcare does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.

Unable to compare Novita Healthcare's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Novita Healthcare's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Novita Healthcare has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Novita Healthcare has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Novita Healthcare improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Novita Healthcare's financial position?


Financial Position Analysis

Novita Healthcare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Novita Healthcare's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Novita Healthcare has no debt.

Novita Healthcare has not taken on any debt in the past 5 years.


Balance Sheet

Low level of unsold assets.

Novita Healthcare has no debt, it does not need to be covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Novita Healthcare has less than a year of cash runway based on current free cash flow.

Novita Healthcare has less than a year of cash runway if free cash flow continues to grow at historical rates of 31.2% each year.


Next Steps

Dividend

What is Novita Healthcare's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Novita Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Novita Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Novita Healthcare has not reported any payouts.

Unable to verify if Novita Healthcare's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Novita Healthcare has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Novita Healthcare's salary, the management and board of directors tenure and is there insider trading?

1.3yrs

Average management tenure


CEO

Glenn Smith 0

1.3yrs

Tenure

0

Mr. Glenn Smith, BA Econ, MBA has been Managing Director of Novita Healthcare Ltd since May 10, 2018 and serves as its Chief Operating Officer. Mr. Smith served as Chief Executive Officer at Novita Healthc ...


Management Age and Tenure

1.3yrs

Average Tenure

The average tenure for the Novita Healthcare management team is less than 2 years, this suggests a new team.


Board Age and Tenure

3.4yrs

Average Tenure

The tenure for the Novita Healthcare board of directors is about average.


Insider Trading

More shares have been bought than sold by Novita Healthcare individual insiders in the past 3 months, but not in substantial volumes.


Recent Insider Transactions

BuyAU$33,74018 Sep 19
Peter Diamond
EntityIndividual
Shares5,000,000
Max PriceAU$0.0067
BuyAU$67,48002 Sep 19
Jefferson Harcourt
EntityIndividual
Role
Member of the Board of Directors
Non-Executive Director
Shares10,000,000
Max PriceAU$0.0067
BuyAU$89802 Sep 19
Susan MacLeman
EntityIndividual
Role
Chairman of the Board
Chairperson of the Board
Shares133,098
Max PriceAU$0.0067
BuyAU$9,20202 Sep 19
Mark Simari
EntityIndividual
Role
Member of the Board of Directors
Non-Executive Director
Shares1,363,637
Max PriceAU$0.0067
BuyAU$3,06702 Sep 19
Glenn Smith
EntityIndividual
Role
Chief Executive Officer
COO & MD
Shares454,546
Max PriceAU$0.0067
BuyAU$5,98819 Jun 19
Glenn Smith
EntityIndividual
Role
Chief Executive Officer
COO & MD
Shares479,790
Max PriceAU$0.012
BuyAU$28,69423 Apr 19
Jefferson Harcourt
EntityIndividual
Role
Member of the Board of Directors
Non-Executive Director
Shares2,000,000
Max PriceAU$0.014
BuyAU$3,73228 Mar 19
Glenn Smith
EntityIndividual
Role
Chief Executive Officer
COO & MD
Shares250,000
Max PriceAU$0.015
BuyAU$2,74604 Mar 19
Susan MacLeman
EntityIndividual
Role
Chairman of the Board
Chairperson of the Board
Shares150,000
Max PriceAU$0.018
BuyAU$10,76120 Dec 18
Jefferson Harcourt
EntityIndividual
Role
Member of the Board of Directors
Non-Executive Director
Shares500,000
Max PriceAU$0.022
BuyAU$1,46812 Dec 18
Glenn Smith
EntityIndividual
Role
Chief Executive Officer
COO & MD
Shares70,210
Max PriceAU$0.021
BuyAU$10,59929 Oct 18
Mark Simari
EntityIndividual
Role
Member of the Board of Directors
Non-Executive Director
Shares500,000
Max PriceAU$0.021
BuyAU$11,31524 Oct 18
Mark Simari
EntityIndividual
Role
Member of the Board of Directors
Non-Executive Director
Shares500,000
Max PriceAU$0.023
BuyAU$61,78515 Oct 18
Peter Diamond
EntityIndividual
Shares2,500,000
Max PriceAU$0.025
BuyAU$4,52109 Oct 18
Glenn Smith
EntityIndividual
Role
Chief Executive Officer
COO & MD
Shares200,000
Max PriceAU$0.023

Ownership Breakdown


Management Team

  • Steve Denaro

    Company Secretary

    • Tenure: 0.5yrs
  • Glenn Smith

    COO & MD

    • Tenure: 1.3yrs
  • Magda Klapakis

    Head of Finance & Financial Controller

    • Tenure: 8.7yrs
    • Compensation: AU$156.14k
  • Hannah Kirk

    Chief Research Officer

    • Tenure: 0yrs
    • Compensation: AU$129.50k

Board Members

  • Sue MacLeman (55yo)

    Chairperson of the Board

    • Tenure: 0.9yrs
  • Mark Simari (50yo)

    Non-Executive Director

    • Tenure: 2.9yrs
    • Compensation: AU$26.67k
  • Jefferson Harcourt

    Non-Executive Director

    • Tenure: 3.5yrs
    • Compensation: AU$30.83k
  • Kim Cornish

    Chairman of Scientific Advisory Board

    • Tenure: 0yrs
  • Gaia Scerif

    Member of Scientific Advisory Board

    • Tenure: 3.4yrs
  • Mark Bellgrove

    Member of Scientific Advisory Board

    • Tenure: 3.4yrs
  • Vicki Anderson

    Member of Scientific Advisory Board

    • Tenure: 3.4yrs
  • Jane Roberts

    Member of Scientific Advisory Board

    • Tenure: 3.4yrs

Company Information

Novita Healthcare Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Novita Healthcare Limited
  • Ticker: AVXA.F
  • Exchange: OTCPK
  • Founded: 2004
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: AU$5.841m
  • Listing Market Cap: AU$3.970m
  • Shares outstanding: 449.31m
  • Website: https://www.novitahealthcare.com.au

Number of Employees


Location

  • Novita Healthcare Limited
  • 1 Crescent Road
  • Ground Floor
  • Glen Iris
  • Victoria
  • 3146
  • Australia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
UV7DB (Deutsche Boerse AG)YesOrdinary SharesDEEURSep 2004
NHLASX (Australian Securities Exchange)YesOrdinary SharesAUAUDSep 2004
AVXA.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDSep 2004
NHLCHIA (Chi-X Australia)YesOrdinary SharesAUAUDSep 2004

Biography

Novita Healthcare Limited engages in the development and commercialization of healthcare technologies in Australia. The company operates through Research and Development, Healthcare/Workforce Management, a ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/04 00:13
End of Day Share Price2019/05/06 00:00
Earnings2018/12/31
Annual Earnings2018/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.